The International Congress on Cyberspace Intelligence and Health 2025

---

Tong Wu
Beijing Ditan Hospital, Capital Medical University, China

Topic: 基于免疫调控的中医药治疗原发性肝癌研究与转化
Immunomodulation-Based Traditional Chinese Medicine for Primary Liver Cancer: Research and Translation

Abstract: The abstract for this keynote will be released soon as the session outline is finalized.

Biography: 吴桐，首都医科大学附属北京地坛医院中西医结合中心主任医师、副教授，长期从事肝病与肿瘤的中西医结合诊疗研究。其工作重点围绕免疫调控导向的中医药方案设计与临床转化，致力于提升原发性肝癌的综合治疗效果。

姚树坤老中医药专家学术经验继承人，北京中西医结合学会肝病专业委员会秘书长，中国中西医结合学会养生学专业委员会青年副主任委员兼秘书，中国研究型医院学会肝病（中西医结合）专业委员会委员，中国中医药研究促进会肝胆病分会理事，以及北京市慢性病防治与健康教育研究会胃肠疾病专业委员会委员。长期从事中西医结合肝病的临床与科研工作，以第一作者或通讯作者在SCI及核心期刊发表论文20余篇，担任副主编参编著作2部。近五年主持校局级课题3项，并参与国家科技重大专项、国家自然科学基金面上项目及医管中心“登峰”人才培养计划等多项研究。

Tong Wu is a protégé of veteran TCM expert Yaoshukun and serves as Secretary-General of the Liver Disease Committee of the Beijing Association of Integrative Medicine. He is also the Deputy Director (Youth) and Secretary of the Health Preservation Committee under the China Association of Integrative Medicine, a member of the Liver Disease (Integrative Medicine) Committee of the Chinese Research Hospital Association, a council member of the Hepatobiliary Disease Branch of the China Association for the Promotion of Chinese Medicine Research, and a committee member of the Gastrointestinal Disease Committee of the Beijing Chronic Disease Prevention and Health Education Association. Dr. Wu has long specialized in integrative clinical and research work on liver diseases, publishing over 20 SCI/core journal papers as first or corresponding author, co-authoring two books as associate editor, leading three university-municipal projects in the past five years, and contributing to multiple national key R&D initiatives, National Natural Science Foundation projects, and the Beijing Hospital Authority “Dengfeng” Talent Program.